Guest guest Posted May 28, 2010 Report Posted May 28, 2010 ------------------------------------------------------------ Aasa (penas7ar@...) has sent this article to you from BMJ: Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study http://www.bmj.com/cgi/content/full/340/may27_1/c2649?eaf ------------------------------------------------------------ I thought you might be interested in this article. ------------------------------------------------------------ This is sent to you as an email-a-friend feature from BMJ at http://bmj.com. Written requests to unsubscribe may be sent to: Customer Service 1454 Page Mill Road Palo Alto, CA 94304 U.S.A. The BMJ Group is one of the world's most trusted providers of medical information for doctors, researchers, health care workers and patients. This email and any attachments are confidential. If you have received this email in error, please do not use it in anyway. Please also kindly notify us immediately by reply and remove it from your system. Any personal views expressed in this email are those of the individual and may not represent those of the BMJ Group. The recipient should check this email and any attachments for presence of viruses. The BMJ Group accepts no liability f or damage caused by any virus transmitted by this email. Emails sent or received by the BMJ Group may be monitored, inc luding monitoring for size, traffic, distribution and content. BMJ Publishing Group Limited trading as BMJ Group. A private limited company, registered in England and Wales under registration number 03102371. Registered office: BMA House, Tavistock Square, London WC1H 9JR, UK. The IP address of the sender was 99.231.137.162. Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.